Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Fiskus W, Mill CP, Issa GC, Piel J, Collins M, Hentemann M, Cuglievan B, Hou H, Jain A, Malovannaya A, Kadia TM, Daver N, Sasaki K, Takahashi K, Hammond D, Senapati J, Loghavi S, Flores LB, Su X, DiNardo CD, Bhalla KN

Open source

DOI
10.1182/blood.2025031486
Published
2026 Jun 4
Container
Blood
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025031486,
  title = {Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.},
  author = {Fiskus W and Mill CP and Issa GC and Piel J and Collins M and Hentemann M and Cuglievan B and Hou H and Jain A and Malovannaya A and Kadia TM and Daver N and Sasaki K and Takahashi K and Hammond D and Senapati J and Loghavi S and Flores LB and Su X and DiNardo CD and Bhalla KN},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025031486},
  url = {https://doi.org/10.1182/blood.2025031486}
}

RIS

TY  - JOUR
TI  - Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.
AU  - Fiskus W
AU  - Mill CP
AU  - Issa GC
AU  - Piel J
AU  - Collins M
AU  - Hentemann M
AU  - Cuglievan B
AU  - Hou H
AU  - Jain A
AU  - Malovannaya A
AU  - Kadia TM
AU  - Daver N
AU  - Sasaki K
AU  - Takahashi K
AU  - Hammond D
AU  - Senapati J
AU  - Loghavi S
AU  - Flores LB
AU  - Su X
AU  - DiNardo CD
AU  - Bhalla KN
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025031486
UR  - https://doi.org/10.1182/blood.2025031486
ER  - 

APA

W, F., CP, M., GC, I., J, P., M, C., M, H., B, C., H, H., A, J., A, M., TM, K., N, D., K, S., K, T., D, H., J, S., S, L., LB, F., X, S., CD, D., & KN, B. (2026). Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.. Blood. https://doi.org/10.1182/blood.2025031486

Source records